clenziderm m.d. system acne therapeutic system
NDC 62032-613, SALICYLIC ACID AND BENZOYL PEROXIDE, kit, from Obagi Cosmeceuticals LLC.
- Product NDC
- 62032-613
- Status
- Listed
- Labeler
- Obagi Cosmeceuticals LLC
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M006
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62032-613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62032-613-09 | 62032061309 | 1 KIT in 1 CARTON (62032-613-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62032-613 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62032-613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62032-613. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.